Shizhong Ke, Fabin Dang, Lin Wang, Jia-Yun Chen, Mandar T Naik, Wenxue Li, Abhishek Thavamani, Nami Kim, Nandita M Naik, Huaxiu Sui, Wei Tang, Chenxi Qiu, Kazuhiro Koikawa, Felipe Batalini, Emily Stern Gatof, Daniela Arango Isaza, Jaymin M Patel, Xiaodong Wang, John G Clohessy, Yujing J Heng, Galit Lahav, Yansheng Liu, Nathanael S Gray, Xiao Zhen Zhou, Wenyi Wei, Gerburg M Wulf, Kun Ping Lu
Induced oncoproteins degradation provides an attractive anti-cancer modality. Activation of anaphase-promoting complex (APC/CCDH1 ) prevents cell-cycle entry by targeting crucial mitotic proteins for degradation. Phosphorylation of its co-activator CDH1 modulates the E3 ligase activity, but little is known about its regulation after phosphorylation and how to effectively harness APC/CCDH1 activity to treat cancer. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1)-catalyzed phosphorylation-dependent cis-trans prolyl isomerization drives tumor malignancy...
April 15, 2024: Nature Communications